Regulation of Cardiac Development by Chromatin Modifying Enzymes
Regulation of Cardiac Development by Chromatin Modifying Enzymes
批准号:
10399458
负责人:
Chinmay M Trivedi
金额:
$41.88万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
未结题
起止时间:
2013-04-01 至 2025-01-31
关键词:
AblationAgeAreaBicuspidBiologyCardiacCardiac developmentCardiovascular DiseasesCartoonsCell Differentiation processChromatinChromatin Remodeling FactorCollagenComplexDNADNA BindingDNA Binding DomainDataDefectDepositionDevelopmentDiseaseEmbryoEnzymesEpidermal Growth Factor ReceptorEpigenetic ProcessExhibitsExtracellular MatrixGene SilencingGenesGenetic TranscriptionGoalsHDAC3 geneHDAC4 geneHeartHistone DeacetylaseHistone H3HistonesHomeostasisHumanHyperplasiaKDM5B geneKRASG12DLysineMAP Kinase GeneMAPK1 geneMesenchymalMesenchymal DifferentiationMethyltransferaseModelingMolecularMorbidity - disease rateMusMutant Strains MiceMutateNoduleNucleic Acid Regulatory SequencesPTPN11 genePathologicPathologyPatientsPharmacological TreatmentPharmacologyPhenotypePhosphorylationPhosphotransferasesPolycombPublishingPulmonary valve structureRas/RafRegulationResearchRoleSignal PathwaySignal TransductionStructureTestingUp-Regulationaortic valveaortic valve disorderbasecalcificationepigenomicsexperimental studygain of functiongenomic locushuman diseaseinterstitial cellloss of functionmortalitymutantnovelosteopontinpostnatalpreventprogramsrecruitstem cellstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
Aortic valve disease is an increasingly prevalent cause of morbidity and mortality, with no current effective
pharmacological treatment. An underlying pathology is often aberrant differentiation of valvular interstitial cells
(VICs) leading to altered composition of extracellular matrix (ECM) and calcification. Although various factors
involved in VIC differentiation have been described, the chromatin modifiers required to maintain mesenchymal
identity of VICs remain largely unknown. Histone deacetylases (Hdacs) lack intrinsic DNA-binding domains but
modify chromatin via their interactions with transcription factors, co-factors, and large multiprotein transcriptional
complexes. We recently published that mouse embryos lacking Hdac3 within the second heart field cardiac
progenitor cells exhibit complete embryonic lethality and severe cardiac developmental defects, including
bicuspid and hyperplastic aortic valve. Our preliminary data suggest a novel and unexpected role of Hdac3 in
postnatal aortic valve homeostasis. Hdac3-null aortic valves exhibit upregulation of a discrete set of
chondrogenic genes, which are frequently elevated in human diseased aortic valves. In murine aortic valves,
Hdac3 recruits components of the Polycomb Repressive Complex 2 (PRC2), including methyltransferase Ezh2,
Eed, and Suz12 to enrich trimethylation of lys27 on histone H3 (H3K27me3), a gene silencing mark, at the
regulatory chondrogenic gene loci. The goal of this research program is to identify how Hdac3 regulates
mesenchymal identity of aortic valvular interstitial cells in both humans and mice. In addition, proposed studies
will identify the mechanisms by which different kinases involved in signaling pathways regulate the
phosphorylation, function, and chromatin recruitment of Hdac3. Despite intense study in the area of epigenetics,
very little is known about the role of epigenetic and chromatin modifiers in the field of aortic valve biology. The
set of experiments outlined in this proposal have broad significance not only for understanding how signaling
pathways intersect with chromatin modifiers to regulate homeostasis of aortic valves, but also could be highly
applicable to the entire field of cardiovascular diseases.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1161/circresaha.121.319587
发表时间:
2021-06-25
期刊:
Circulation research
影响因子:
20.1
作者:
[Janardhan HP, Saheera S, Jung R, Trivedi CM]
通讯作者:
Trivedi CM
DOI:
10.1002/dvdy.24563
发表时间:
2017-12
期刊:
Developmental dynamics : an official publication of the American Association of Anatomists
影响因子:
--
作者:
[Milstone ZJ, Lawson G, Trivedi CM]
通讯作者:
Trivedi CM
DOI:
10.1172/jci.insight.153033
发表时间:
2022-09-08
期刊:
JCI INSIGHT
影响因子:
8
作者:
[Janardhan, Harish P., Dresser, Karen, Hutchinson, Lloyd, Trivedi, Chinmay M.]
通讯作者:
Trivedi, Chinmay M.
Epigenetic regulation of lymphatic development
-
批准号:10662551
-
项目类别:
-
资助金额:$60.97万
-
财政年份:2018
-
负责人:Chinmay M Trivedi
-
依托单位:
Epigenetic regulation of lymphatic development
-
批准号:10540097
-
项目类别:
-
资助金额:$60.97万
-
财政年份:2018
-
负责人:Chinmay M Trivedi
-
依托单位:
Epigenetic regulation of lymphatic development
-
批准号:10192805
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2018
-
负责人:Chinmay M Trivedi
-
依托单位:
Epigenetic regulation of lymphatic development
-
批准号:9922367
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2018
-
负责人:Chinmay M Trivedi
-
依托单位:
Regulation of Cardiac Development by Chromatin Modifying Enzymes
-
批准号:9045696
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2013
-
负责人:Chinmay M Trivedi
-
依托单位:
Regulation of Cardiac Development by Chromatin Modifying Enzymes
-
批准号:8669159
-
项目类别:
-
资助金额:$40.98万
-
财政年份:2013
-
负责人:Chinmay M Trivedi
-
依托单位:
Regulation of Cardiac Development by Chromatin Modifying Enzymes
-
批准号:8479285
-
项目类别:
-
资助金额:$40.39万
-
财政年份:2013
-
负责人:Chinmay M Trivedi
-
依托单位:
Regulation of Cardiac Development by Chromatin Modifying Enzymes
-
批准号:9251882
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2013
-
负责人:Chinmay M Trivedi
-
依托单位:
Hdac2 and Hopx: Regulators of Cardiac Development
-
批准号:8307117
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Chinmay M Trivedi
-
依托单位:
Hdac2 and Hopx: Regulators of Cardiac Development
-
批准号:8316199
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Chinmay M Trivedi
-
依托单位:
Hdac2 and Hopx: Regulators of Cardiac Development
-
批准号:8528697
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2011
-
负责人:Chinmay M Trivedi
-
依托单位:
Hdac2 and Hopx: Regulators of Cardiac Development
-
批准号:8034827
-
项目类别:
-
资助金额:$9.57万
-
财政年份:2010
-
负责人:Chinmay M Trivedi
-
依托单位:
Hdac2 and Hopx: Regulators of Cardiac Development
-
批准号:7771308
-
项目类别:
-
资助金额:$9.72万
-
财政年份:2010
-
负责人:Chinmay M Trivedi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: